Sorilla Prey

10PUBLICATIONS
60CO-AUTHORS
Gene and molecular therapyNeural engineeringImmunogenetics (incl. genetic immunology)NanomedicineMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 12, 2026
COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.

|Jun 10, 2026
Telocyte-derived pentraxin 3 enables vascular pruning as a key driver in infantile hemangioma regression.

|Dec 22, 2025
Brief Communication: Severe Immuno-Induced Rhinosinusitis With Deafness After Ipilimumab and Nivolumab Combination for Melanoma, and Review of the Literature.

Maëva Boyer, Mélodie Kerimian, Alix Ribadeau Dumas

|Jun 27, 2025
BO-112 Plus Pembrolizumab for Patients With Anti-PD-1-Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203.

Iván Márquez-Rodas, Caroline Dutriaux, Philippe Saiag

|Nov 25, 2024
Long-term effects of sirolimus treatment for slow-flow vascular malformations: Real-world evidence from the French observational multicentre SIROLO study.

Cécilia Maillet, Olivia Boccara, Stéphanie Mallet

|Jun 16, 2023
Brief Communication: Lambert-Eaton Myasthenic Paraneoplastic Syndrome Associated With Merkel Cell Carcinoma Successfully Treated by Immune Checkpoint Inhibitors: 2 Cases.

Marion Gra, Anne Pham-Ledard, Emilie Gerard

Pageof 2

Frequent Collaborators

2 joint publications

Olivia Boccara

2 joint publications

Caroline Robert

2 joint publications

François Moisan

2 joint publications

Alain Taieb